Clinical Trials in San Antonio

Showing 3041-3060 of 7,028 trials

Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury

NCT04280965

A pilot study to evaluate feasibility for a full-scale merit application. Specifically, for veterans considering prolonged exposure (PE) therapy, following the model established by Foa et al, we need to establish safety, and feasibility of quetiapine compared to treatment as usual (TAU) which employs multiple medications commonly used for PTSD in the VA system.

Post Traumatic Stress Disorder

The University of Texas Health Science Center at San Antonio28 participantsStarted Feb 2019

San Antonio, Texas, United States

COMPLETEDPhase 2< 1 mile

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

NCT04855240

To evaluate the efficacy of ACP-044 compared with placebo in the treatment of acute postoperative pain

Acute Postoperative PainBunionectomy

ACADIA Pharmaceuticals Inc.239 participantsStarted Mar 2021

Anaheim, California, United States • Pasadena, Maryland, United States • San Antonio, Texas, United States +1 more locations

COMPLETEDPhase 2< 1 mile

FX-322 in Adults With Stable Sensorineural Hearing Loss

NCT04120116

This is a phase 2a single and repeat dose exploratory efficacy study of intratympanic FX-322 compared to placebo in healthy male and female adults with stable sensorineural hearing loss.

Sensorineural Hearing LossNoise Induced Hearing LossSudden Sensorineural Hearing Loss

Frequency Therapeutics95 participantsStarted Oct 2019

Fresno, California, United States • Torrance, California, United States • Colorado Springs, Colorado, United States +13 more locations

Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

FX-322 in Adults With Stable Sensorineural Hearing Loss

Find Trials by Condition in San Antonio

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors

Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)

The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial

S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

Safety Study of SEA-CD40 in Cancer Patients

ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib

Relative Bioavailability of LY03010 Compared to Listed Drug

PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study

A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer

Rapid Diagnostics for HIV and Hepatitis